Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (261-270 of 434) with videos related to

Pageof 44
Sort By:
Scientific Reports|March 10, 2017
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
The New England Journal of Medicine|February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Rheumatology (Oxford, England)|June 17, 2024
Assessment of damage in Takayasu's arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
EULAR Rheumatology Open|June 29, 2026
Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trialPeter A Merkel, Bernhard Hellmich, Christian Pagnoux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With PolyangiitisRennie L Rhee, Jiarui Lu, Kyle Bittinger, et al.
Arthritis and Rheumatism|March 5, 2011
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosisRonald J Falk, Wolfgang L Gross, Loïc Guillevin, et al.
The Journal of Rheumatology|September 3, 2017
Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016Antoine G Sreih, Fatma Alibaz-Oner, Tanaz A Kermani, et al.
Arthritis and Rheumatism|December 16, 2003
Domains of health-related quality of life important to patients with giant cell arteritisDavid B Hellmann, Misty L Uhlfelder, John H Stone, et al.
Scientific Reports|April 6, 2017
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
ACR Open Rheumatology|March 30, 2021
Effects of the COVID-19 Pandemic on Patients Living With VasculitisShubhasree Banerjee, Michael George, Kalen Young, et al.
Pageof 44

Showing results (261-270 of 434) with videos related to

Sort By:
Pageof 44
Scientific Reports|March 10, 2017
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
The New England Journal of Medicine|February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Rheumatology (Oxford, England)|June 17, 2024
Assessment of damage in Takayasu's arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
EULAR Rheumatology Open|June 29, 2026
Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trialPeter A Merkel, Bernhard Hellmich, Christian Pagnoux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With PolyangiitisRennie L Rhee, Jiarui Lu, Kyle Bittinger, et al.
Arthritis and Rheumatism|March 5, 2011
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosisRonald J Falk, Wolfgang L Gross, Loïc Guillevin, et al.
The Journal of Rheumatology|September 3, 2017
Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016Antoine G Sreih, Fatma Alibaz-Oner, Tanaz A Kermani, et al.
Arthritis and Rheumatism|December 16, 2003
Domains of health-related quality of life important to patients with giant cell arteritisDavid B Hellmann, Misty L Uhlfelder, John H Stone, et al.
Scientific Reports|April 6, 2017
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
ACR Open Rheumatology|March 30, 2021
Effects of the COVID-19 Pandemic on Patients Living With VasculitisShubhasree Banerjee, Michael George, Kalen Young, et al.
Pageof 44